Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07792980
Recruiting
AI-Assisted Microbiome Analysis for Evaluating the Efficacy of MPRO3 and Gut Environmental Changes in Colon Cancer Surgery Patients
Not applicable · South Korea · 1 site
Registry update: 28 Aug 2026
NCT07647640
Recruiting
Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study
Not applicable · Netherlands · 3 sites
Registry update: 13 Oct 2026
NCT07602907
Recruiting
Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion Study
Phase 2 · China · 1 site
Registry update: 11 Aug 2026
NCT07752979
Recruiting
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Phase 2 · Puerto Rico, United States · 64 sites
Registry update: 27 Oct 2026
NCT07448974
Recruiting
Vitamin D and Type 2 Diabetes - Treat-To-Target
Phase 3 · United States · 1 site
Registry update: 18 Aug 2026
NCT07231380
Recruiting
A Comparison of Cyclic Manual Direct Aspiration Thrombectomy (Plunger Technique) vs. Static Manual Direct Aspiration Thrombectomy for Treatment of Acute Large Vessel Occlusion Stroke
Not applicable · United States · 1 site
Registry update: 6 Oct 2026
NCT05776927
Recruiting
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Phase 3 · Argentina, Spain, France, Hungary, Poland, Romania, Slovakia, Taiwan, South Africa · 22 sites
Registry update: 15 Oct 2026
NCT07698600
Recruiting
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
Phase 1 · United States, South Africa · 4 sites
Registry update: 14 Oct 2026
NCT07745504
Recruiting
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Phase 3 · Greece, Hungary, Portugal, Serbia, Sweden, United States · 36 sites
Registry update: 4 Sept 2026
Conflicting statuses (not updated in the registry for 2 months)
NCT07656142
Recruiting
A Personalized Mobile Application Providing Temperature-Related Health Risk Warnings and Protective Recommendations for Patients With Chronic Obstructive Pulmonary Disease
Not applicable · China · 4 sites
Registry update: 23 Oct 2026
NCT06593392
Recruiting
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Phase 2 · United Arab Emirates, China, Spain, United Kingdom, Greece, Israel, Saudi Arabia · 18 sites
Registry update: 23 Oct 2026
NCT07779798
Recruiting
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.
Phase 1 · United States · 4 sites
Registry update: 21 Oct 2026
NCT07719530
Recruiting
Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
Phase 2 · China · 1 site
Registry update: 20 Aug 2026
NCT07760688
Recruiting
Structured Periprocedural Nursing Interventions in Men Undergoing Transrectal Prostate Biopsy
Not applicable · 1 site
Registry update: 12 Aug 2026
NCT07857668
Recruiting
LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial)
Not applicable · China · 1 site
Registry update: 5 Oct 2026
NCT07650240
Recruiting
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT07625644
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Phase 3 · Australia, Bulgaria, Canada, Czechia, Germany, Spain, France, Georgia, Greece, Hungary, Italy, Poland, Serbia, United States · 62 sites
Registry update: 15 Oct 2026
NCT05253131
Recruiting
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Phase 2 · United States · 1 site
Registry update: 24 Aug 2026
NCT07606352
Recruiting
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
Phase 2 · Australia · 8 sites
Registry update: 17 Sept 2026
NCT07910708
Recruiting
GN001 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and B-Cell Acute Lymphoblastic Leukemia
Phase 1 · China · 2 sites
Registry update: 2 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.